Business Context and Reporting Period
Company: SELLAS Life Sciences Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 6, 2018 (Events reported between February 6 and February 9, 2018)
Context: The Company entered into a series of Warrant Exchange Agreements with holders of warrants issued in its February 2017 registered offering. These agreements involve the surrender of warrants in exchange for common stock or a convertible promissory note.
Key Financial Metrics and Agreements
The filing details four specific agreements regarding the exchange of warrants for equity or debt instruments. No revenue, profit, or cash flow data is provided in this filing.
- CVI Investments, Inc.: Surrendered warrant for 99,333 shares. In exchange, the Company agreed to issue shares equal to $232,440 divided by the closing sale price on the first trading day following a public announcement of a financing transaction.
- Anson Investments Master Fund LP: Surrendered warrant for 30,000 shares. The Company issued 12,536 shares of Common Stock on February 8, 2018.
- Sabby Healthcare Master Fund Ltd.: Surrendered warrants for 83,333 shares. The Company agreed to issue shares equal to $195,000 divided by the closing sale price on the closing date (expected by February 13, 2018).
- Hudson Bay Master Fund Ltd.: Surrendered warrant for 146,666 shares. The Company issued a convertible promissory note with a principal amount of $343,200.
Hudson Bay Note Terms
- Principal: $343,200
- Interest Rate: 5% per annum (increases to 18% per annum upon an event of default).
- Maturity Date: August 9, 2018.
- Conversion Price: $7.00 per share (convertible after April 30, 2018, subject to a 9.99% beneficial ownership limit).
- Default Conversion: If an event of default occurs, the conversion price becomes the lower of the standard price or 70% of the lowest volume-weighted average price over the prior 10 trading days.
Material Changes and Unusual Items
This filing represents a material change in the Company's capital structure through the conversion of existing warrant liabilities into equity or debt obligations. The agreements include "most favored nation" provisions, ensuring that if the Company enters into more favorable terms with other warrant holders, the terms of these agreements will be modified to match.
Specific restrictions were placed on the selling of shares by CVI and Sabby: neither party may sell more than 2% of the daily trading volume of Common Stock on any one trading day during the 30-day period following the closing of the exchange.
Guidance, Outlook, and Risks
Outlook: The filing does not provide financial guidance or management commentary regarding future operations or earnings.
Risks and Contingencies:
- Termination Risk: The CVI Agreement terminates if the exchange does not close by February 28, 2018. The Sabby Agreement terminates if the exchange does not close by February 13, 2018.
- Dilution Risk: The issuance of shares to CVI, Anson, and Sabby, and the potential conversion of the Hudson Bay Note, will increase the number of outstanding shares, potentially diluting existing shareholders.
- Default Risk: The Hudson Bay Note carries a significant penalty interest rate (18%) and a discounted conversion price (70% of market low) in the event of default, which includes suspension of trading, failure to deliver shares, or failure to pay amounts due.
Investor Verification Checklist
- Verify the closing status of the CVI and Sabby agreements, as they are contingent on specific dates (Feb 28 and Feb 13, 2018, respectively).
- Confirm the exact number of shares issued to CVI and Sabby once the financing transaction announcement and closing dates are finalized.
- Monitor the Company's ability to meet the August 9, 2018, maturity date of the $343,200 Hudson Bay Note to avoid default penalties.
- Review the full text of the agreements filed in the Form 10-K for the year ended December 31, 2017, for complete terms and conditions.
- Assess the impact of the 9.99% beneficial ownership limit on the Hudson Bay Note's convertibility.